廣告
香港股市 已收市
  • 恒指

    18,089.93
    +17.03 (+0.09%)
     
  • 國指

    6,477.24
    +12.75 (+0.20%)
     
  • 上證綜指

    2,972.53
    +22.53 (+0.76%)
     
  • 道指

    38,975.11
    -137.05 (-0.35%)
     
  • 標普 500

    5,458.92
    -10.38 (-0.19%)
     
  • 納指

    17,729.12
    +11.47 (+0.06%)
     
  • Vix指數

    12.87
    +0.03 (+0.23%)
     
  • 富時100

    8,223.84
    -23.95 (-0.29%)
     
  • 紐約期油

    81.14
    +0.31 (+0.38%)
     
  • 金價

    2,308.30
    -22.50 (-0.97%)
     
  • 美元

    7.8085
    -0.0001 (-0.00%)
     
  • 人民幣

    0.9301
    +0.0005 (+0.05%)
     
  • 日圓

    0.0484
    -0.0002 (-0.49%)
     
  • 歐元

    8.3430
    -0.0223 (-0.27%)
     
  • Bitcoin

    61,694.62
    -167.62 (-0.27%)
     
  • CMC Crypto 200

    1,282.03
    -1.76 (-0.14%)
     

Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs

Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs

Popular weight-loss drugs have boosted Novo Nordisk and Eli Lilly. After huge gains, the drugmakers' stocks now face this risk.